Back to Results
First PageMeta Content
Medicine / Dipeptidyl peptidase-4 inhibitors / Thiazolidinediones / Amides / Eli Lilly and Company / Anti-diabetic medication / Metformin / Vildagliptin / Pioglitazone / Chemistry / Anti-diabetic drugs / Organic chemistry


ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 1 1.
Add to Reading List

Document Date: 2013-08-19 04:29:02


Open Document

File Size: 641,05 KB

Share Result on Facebook

Company

NVR / /

Currency

CYP / /

Event

Product Recall / Product Issues / /

IndustryTerm

co-administered medicinal products / thyroid products / medicinal product / oral antidiabetic medicinal products / suspect medicinal products / medicinal products / /

MedicalCondition

rare hereditary problems / gastro-oesophageal reflux / congestive heart failure / liver dysfunction / skin disorders / ESRD / diabetes / fever / persistent / severe abdominal pain / Lapp lactase deficiency / hepatic dysfunction / Contraindications Hypersensitivity / diabetes mellitus / diabetic ketoacidosis / angioedema / pancreatitis / hepatitis / dizziness / end-stage renal disease / acute pancreatitis / Infections / Cardiac failure A / cholestasis / /

MedicalTreatment

oral therapy / /

Organization

New York Heart Association / /

Position

Major / General / /

Product

pioglitazone / ramipril / valsartan / simvastatin / Digoxin / glimepiride / treatment with Galvus / glyburide / PHARMACEUTICAL FORM Tablet / Excipients The tablets / Galvus 50 mg / QUALITATIVE AND QUANTITATIVE COMPOSITION Each tablet / /

SocialTag